Matt knows how to close the deal. He can meet a woman, charm her, land her in bed… and that’s when the worrying begins. More often than not, he reaches orgasm too soon. He desperately wants his body to be cooler and calmer, to handle the great gift he’s been rewarded with. When it doesn’t, he feels inadequate, defective.
“I can’t control it,” the 23-year-old Iowan says, “and I can’t figure out why.”
Science has a name for Matt’s problem, one that sounds both sterile and judgmental: premature ejaculation. As a study in theArchives of Sexual Behavior notes, PE is the most common male sexual dysfunction. According to estimates, somewhere between 20 percent and 30 percent of men experience it, with many men doing almost anything to last longer in the sack. Those we spoke with said they’ve downed beers, undergone hypnosis, and even tied elastic bands around their penises.
It’s easy to see why Big Pharma is betting they’d also pop a pill.
Last year in Europe, Johnson & Johnson began selling the first prescription drug designed specifically for treating PE. It’s called Priligy, and clinical trials reveal that it can triple the time to ejaculation for men who normally last just a minute or two. Right now it’s available in a handful of countries, including Germany, Spain, and Italy. Matt, however, is out of luck—Priligy isn’t for sale in the United States. In 2005, the FDA rejected Johnson & Johnson’s application for approval, although a company officer says it has a raft of new research and plans to renew discussions with the FDA.*
If the FDA eventually does approve Priligy, it will be a watershed moment for a condition that received little attention from researchers until a decade ago. Doctors will have a proven solution for men who’ve been robbed of sexual satisfaction. As Priligy advertising infiltrates the media and PE becomes acknowledged as common and treatable, the stigma surrounding it will fade. A conversation will begin, and suffering men will become emboldened with the knowledge that they’re not alone.
But a much-heralded, mass-marketed release of a PE drug could also have an entirely different, more dangerous effect. Some researchers believe that a Priligy advertising blitz could bend men’s expectations by stressing stamina as their sole measure of sexual prowess, sowing self-doubt and fears of PE in the minds and beds of perfectly normal guys.
In other words, they worry that the treatment could cause the condition.
Source : Men’s Health